申基生物成立于2018年,專注于為客戶提供生命科學(xué)領(lǐng)域上游原料的整體解決方案。公司多年來(lái)致力于生命科學(xué)卡脖子原料的研發(fā)和產(chǎn)業(yè)化,現(xiàn)已具有抗體發(fā)現(xiàn)平臺(tái)、mRNA原液制備平臺(tái)、mRNA-LNP制劑工藝平臺(tái)、寡核苷酸制備平臺(tái)、酶定向進(jìn)化平臺(tái)等技術(shù),在此驅(qū)動(dòng)下,衍生細(xì)胞基因治療原料、基因核酸藥物原料以及IVD原料三大產(chǎn)品板塊。
?
Founded in 2018, Jiangsu Synthgene Biotechnology Co., Ltd. focuses on providing overall solutions for upstream raw materials in life sciences. Over the years, Synthgene is committed to the development and industrialization of life science insurmountable raw materials. Currently, Synthgene antibody discovery platform, mRNA stock solution preparation platform, mRNA-LNP preparation process platform, oligonucleotide preparation platform, enzyme directed evolution platform contribute to derivative three product segments include cell gene therapy raw materials, gene nucleic acid drug raw materials and IVD raw materials.?